Last reviewed · How we verify
NCT04463225
The Network Study: Soldiers Connecting for Work and Health
NA trial testing Internet-Delivered Brief Intervention in Alcohol Use Disorder in 450 participants. Status unknown.
28 February 2024
Quick facts
| Lead sponsor | Cornell University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 450 |
| Start date | 30 March 2021 |
| Primary completion | 28 February 2024 |
| Estimated completion | 31 March 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Internet-Delivered Brief Intervention
Conditions studied
- Alcohol Use Disorder — all drugs for Alcohol Use Disorder →
- Depression — all drugs for Depression →
Sponsor
Cornell University
Who can join
Adults 18 to 62, any sex, with Alcohol Use Disorder or Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will examine the efficacy of an internet-based brief intervention designed to reduce risky behavior in Soldiers as they transition from Active Duty into the civilian workforce as a Veteran. Up to 700 soldiers intending to separate from the Army will be recruited, with the intention of drawing a final sample of 450 participants. Study participants will be randomly assigned to either the intervention or the control group, stratified by age and gender.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04463225
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alcohol Use Disorder
Currently open trials in the same condition.
- NCT06860607 — Environment and Alcohol: A Pilot Study · Phase 1 · recruiting
- NCT07325266 — Human Laboratory Study of Apremilast for Alcohol Use Disorder · Phase 2 · recruiting
- NCT07046819 — Tirzepatide in MetALD · Phase 2 · recruiting
- NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting
- NCT07056894 — Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis · NA · recruiting
Other Cornell University trials
Trials by the same sponsor.
- NCT07439198 — The Influence of Water Intake on Food Intake at Meals Varying in Moisture · NA · not yet recruiting
- NCT07224412 — A Digital Intervention to Promote Preschool Nutrition and Activity: The eHEROs Study · NA · recruiting
- NCT06880510 — The Locus Coeruleus, Norepinephrine and Cognitive Aging · NA · recruiting
- NCT06870526 — Feasibility of Online-supported Delivery Bringing Optimal Nutrition to Diverse Low-income Households With Children · NA · completed
- NCT06988410 — Income Volatility and Mental Health, Full Experiment · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04463225 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cornell University
- Last refreshed: 26 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04463225.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing